Explainable and interpretable models for predicting early-onset hypertension in the Tlalpan 2020 cohort - Report - MDSpire

Explainable and interpretable models for predicting early-onset hypertension in the Tlalpan 2020 cohort

  • By

  • Guadalupe Gutiérrez-Esparza

  • Mireya Martínez-García

  • Luis M. Amezcua-Guerra

  • Martín Montes Rivera

  • Enrique Hernández-Lemus

  • June 2, 2026

  • 0 min

Share

Clinical Report: Interpretable Models for Forecasting Early-Onset Hypertension

Overview

This study introduces DSRegPSOP, a symbolic regression approach that develops interpretable models for predicting early-onset hypertension. The models demonstrate predictive performance comparable to advanced machine learning techniques while maintaining clinical interpretability.

Background

Early-onset hypertension is a significant health concern due to its association with increased cardiovascular risk. Understanding the multifactorial determinants of hypertension is crucial for early intervention and prevention strategies. The Tlalpan 2020 cohort provides a unique dataset to explore these determinants in clinically healthy adults, enhancing the potential for effective predictive modeling.

Data Highlights

No numerical data available.

Key Findings

  • DSRegPSOP produced interpretable mathematical models for early-onset hypertension.
  • The models maintained predictive performance comparable to state-of-the-art machine learning algorithms.
  • Key predictors of early-onset hypertension were identified through the models.
  • The study utilized a nested case-control design based on a 10-year prospective cohort.
  • Addressed class imbalance using oversampling and SMOTE-based strategies.

Clinical Implications

The development of interpretable models like DSRegPSOP can enhance clinical decision-making by providing clear insights into hypertension risk factors. These models may support early prevention strategies, pending further validation in independent cohorts.

Conclusion

DSRegPSOP offers a promising approach to hypertension risk assessment, emphasizing the need for interpretable models in clinical practice. Future validation studies are essential to confirm its utility in diverse populations.

Related Resources & Content

  1. European Journal of Preventive Cardiology, 2023 -- Cardiovascular risk estimation: can a risk prediction model derived in one country be used in another?
  2. npj Digital Medicine, 2023 -- A Decade-Long Population Study on the Progression of Multimorbidity Burden in a Cohort of 5.5 Million Adults
  3. conexiant, 2023 -- ML Model May Predict Preeclampsia Risk
  4. BMC Psychiatry, 2023 -- Creation, assessment, and illustration of a machine learning-driven model to predict depression risk among patients with sleep disorders
  5. American Heart Association, 2025 -- 2025 High Blood Pressure (BP) Guideline
  6. European Heart Journal, 2024 -- 2024 ESC Guidelines for the management of elevated blood pressure and hypertension
  7. Hypertension and Cardiovascular Risk
  8. 2025 High Blood Pressure (BP) Guideline - Professional Heart Daily | American Heart Association
  9. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension | European Heart Journal | Oxford Academic

Original Source(s)

Related Content